Actively Recruiting
Long-term of Remote Ischemic Preconditioning and Mindfulness in Patients With Mild Hypertension
Led by Henan Institute of Cardiovascular Epidemiology · Updated on 2026-04-06
400
Participants Needed
1
Research Sites
491 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
According to the latest survey data of China hypertension annual meeting, there are about 300 million patients with hypertension in China, with 10 million new cases of hypertension each year, and there is an obvious trend of younger people. In particular, young and middle-aged people are in a state of mild hypertension for a long time, which causes great pressure on health and medical treatment. At present, the main clinical measures for mild hypertension are to change their eating habits, quit smoking and alcohol, exercise and other lifestyle changes, as well as drug control. For most patients with mild hypertension, drug control is not the best choice. It has been reported that remote ischemic preconditioning (RIPC) may play an effective role in reducing blood pressure .The purpose of this study was to investigate the extent of long-term application of RIPC to reduce blood pressure in patients with mild hypertension.
CONDITIONS
Official Title
Long-term of Remote Ischemic Preconditioning and Mindfulness in Patients With Mild Hypertension
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosed with mild hypertension (systolic blood pressure 140-159 mmHg; diastolic blood pressure 90-99 mmHg)
You will not qualify if you...
- Cannot tolerate remote ischemic preconditioning (RIPC)
- Have non-essential hypertension
- Have uncontrolled severe arrhythmia, diabetes, or electrolyte disturbances
- Have severe organic diseases such as acute myocardial infarction, cardiac insufficiency, or abnormal renal function
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Fuwai central China Cardiovascular hospital
Zhengzhou, Henan, China, 450008
Actively Recruiting
Research Team
E
En Li
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
FACTORIAL
Primary Purpose
TREATMENT
Number of Arms
4
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here